6N2-17930-67526
4 vaccinations
2 coded responses
34 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 403 / KY
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
P42-16216-22550
Child or adolescent in my care · Female · 2022-06-27
5XA-60380-66372
Child or adolescent in my care · Female · 2022-08-17
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-11-09
Dose 3 — Pfizer-BioNTech
- 2022-01-08
-
2022-10-05
Dose 4 — Moderna
-
2022-10-05
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2022-10-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-10-07
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain, Oedema peripheral — Feeling: Good · Site: SwellingFree text: Axilla pain and swellingMedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
-
2022-10-19
Survey response — day 14, dose 4MedDRA: Respiratory tract infection — Feeling: GoodFree text: Non COVID respiratory infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-26
- 2022-11-04
- 2022-11-11
- 2022-11-16
- 2023-01-04
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-09 | Pfizer-BioNTech | No |
| 4 | 2022-10-05 | Moderna | No |
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Axilla pain and swelling
Release 12 — day 14, dose 4
Symptoms: Non COVID respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract infection | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release